IMA Health
HOME
COURSES
← Back to course
Conference 2022 PRO
2022.B01.P – Welcome: Dr. Paul Marik and Dr. Pierre Kory
2022.L01.P – Pathology of Disease
2022.L02.P – Epidemiology of Vaccine Injury
2022.L03.P – I-RECOVER Protocol
2022.L04.P – Treating Spike-induced Disease
2022.L05.P – Autophagy
2022.L06.P – Low Dose Naltrexone
2022.L07.P – Neurological Impacts
2022.L08.P – Endocrinological Indications
2022.L09.P – Mitochondrial Dysfunction
2022.L10.P – Reproductive Issues
2022.L11.P – Micro-clotting
2022.L12.P – Reactivation of Chronic Disease
2022.L13.P – Hyperbaric Oxygen Therapy
2022.L14.P – Apheresis, Ozone, and Other Therapies
2022.L15.P – Final Q&A
44 min
2022.B02.P – Closing: Dr. Paul Marik and Dr. Pierre Kory
9 min

2022.L06.P – Low Dose Naltrexone

Lecture abstract: According to the U.S. General Accountability Office, as many as 23 million Americans suffer from long COVID. Fortunately, we have a new weapon in our arsenal: low-dose naltrexone (LDN), a medication discovered in the 1980s as a potential treatment for autoimmune disease and fibromyalgia. By 2016, this unique medication had over 300,000 users and more than 60 research …

Supplementary Files
Previous lesson 2022.L05.P – Autophagy
Next lesson 2022.L07.P – Neurological Impacts

We believe knowledge should be accessible to everyone-no paywalls, no barriers,
just open doors to honest medicine.

We can’t do this alone; it is only possible because of the generosity of supporters. We suggest a donation of $50 to $100. But please know: every dollar counts, and your support-at any level-helps us continue this vital work and keep our resources free for all.

Support our Work